Daša Zupančič Selected Research

Daša Zupančič Research Topics

8	Neoplasms (Cancer) 11/2023 - 11/2015
5	Urinary Bladder Neoplasms (Bladder Cancer) 07/2022 - 01/2014
4	Carcinogenesis 11/2023 - 05/2011
3	Carcinoma (Carcinomatosis) 07/2020 - 05/2011
2	Cystitis 07/2022 - 01/2014
1	Pre-Eclampsia (Preeclampsia) 01/2022
1	Interstitial Cystitis (Interstitial Cystitis, Chronic) 03/2021
1	Papillary Carcinoma 01/2014
1	Hyperplasia 05/2011
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2011

4	LectinsIBA 11/2023 - 01/2014
2	jacalinIBA 11/2023 - 07/2020
2	Glycoproteins (Glycoprotein)IBA 01/2023 - 01/2014
2	Vitamin A (Retinol)FDA LinkGeneric 03/2021 - 06/2020
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2021 - 06/2020
2	Purinergic Receptors (Receptors, Purine)IBA 03/2021 - 01/2014
2	Proteins (Proteins, Gene)FDA Link 03/2021 - 01/2014
2	CarbohydratesIBA 01/2019 - 01/2014
2	UroplakinsIBA 01/2014 - 01/2014
1	SugarsIBA 11/2023
1	ethylisopropylamiloride (EIPA)IBA 11/2023
1	Amiloride (Midamor)FDA LinkGeneric 11/2023
1	Epidermal Growth Factor (EGF)IBA 11/2023
1	Plant LectinsIBA 11/2023
1	diazonaphthalenedisulfonic acid (NDS)IBA 07/2022
1	NanodiamondsIBA 07/2022
1	AntioxidantsIBA 03/2021
1	RetinoidsIBA 03/2021
1	Transient Receptor Potential ChannelsIBA 03/2021
1	Keratins (Keratin)IBA 03/2021
1	AntigensIBA 07/2020
1	Transcription Factors (Transcription Factor)IBA 06/2020
1	NitrosaminesIBA 06/2020
1	Carrier Proteins (Binding Protein)IBA 01/2019
1	4,4'-dinitro-2,2'-stilbenedisulfonic acid (DNDS)IBA 01/2018
1	oxidized low density lipoproteinIBA 11/2015
1	Phenobarbital (Luminal)FDA Link 01/2014
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2014
1	Drinking WaterIBA 05/2011
1	ButylhydroxybutylnitrosamineIBA 05/2011

4	Therapeutics 11/2023 - 01/2014
1	Precision Medicine 07/2022
1	Cesarean Section (Caesarean Section) 01/2022
1	Chemoprevention 03/2021
1	Aftercare (After-Treatment) 11/2015